Semaglutide improves heart failure symptoms and reduces loop diuretic dose

FHS
May 13, 2024
5:02 pm

Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF) regardless of diuretic use, according to late breaking research presented today at Heart Failure 2024, a scientific congress of the European Society of Cardiology.

Decentralized trials company Science 37 to go private in deal with diagnostics startup eMed

Science 37, one of the startups that fueled the rise in decentralized clinical trials, will go private and see its one-time $1 billion valuation evaporate

January 30, 2024

Health Gorilla & Amwell Expands Digital Diagnostic Lab Ordering for Clinicians

What You Should Know: – Health Gorilla, a leading interoperability provider, and Amwell, a global leader in hybrid care enablement, announced a new lab capability within Amwell’s

September 26, 2023

Quality and Sustainability: The Balancing Act for Pharma Manufacturing

Share this article Credit: EXTREME-PHOTOGRAPHER/ GettyImages.com Trends in sustainability and quality assurance were key themes discussed amongst panelists at Convention on Pharmaceutical Ingredients (CPHI) Europe

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.